Group 1 - The article highlights the strong performance of European equities, suggesting that investors may want to increase their exposure to this asset class [1] - Two specific ETFs are mentioned as potential investment options: the iShares Europe ETF (NYSEARCA: IEV) and the iShares MSCI Eurozone ETF (BATS: EZU) [1]

NEW YORK, July 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced that it will hold a conference call on Thursday, August 7, 2025, at 5:00 PM ET following the release of its second quarter 2025 financial results. The earnings conference call may be accessed by dialing 1-888-699-1199. A live webcast will also be available on the Investor Relations section of the AWH w ...

【海外债市】 北美市场方面，当地时间周三（6月25日），美债收益率全线走低，2年期美债收益率跌4.02BPs报 3.7786%，3年期美债收益率跌1.14BPs报3.7484%，5年期美债收益率跌1.59BP报3.845%，10年期美债收 益率跌0.59BP报4.2906%，30年期美债收益率跌0.31BP报4.8311%。 新华财经北京6月26日电（王菁）债市周四（6月26日）稍回暖，国债期货主力多数收平，银行间现券收 益率回落1BP左右；公开市场单日净投放3058亿元，临近季末，资金利率涨跌互现，月内品种仍延续上 行。 机构认为，总量工具观察期，维持流动性充裕诉求下，预计MLF、买断式逆回购等常规流动性工具将 维持净投放。央行净投放展示呵护态度，但季末资金面仍存扰动，机构交易偏谨慎。债市关键变量仍然 缺位，震荡格局难免。 【行情跟踪】 国债期货收盘多数持平，30年期主力合约涨0.10%报120.720，10年期主力合约跌0.02%报108.950，5年 期主力合约持平于106.170，2年期主力合约持平于102.510。 银行间主要利率债收益率纷纷下行。截至发稿，30年期国债"25超长特别国债02"收益率 ...

M Update Government Bond Auctions: The Month Ahead We review the supply, coupon, and redemption picture for the US, UK, Euro, JPY, AUS, NZ, and CAN government bond markets over the next month. This week, G7 net DV01 is expected to be $109.3mn/bp, compared to an average* $72mn/bp; US $82mn/ bp; Euro $17.1mn/bp; Japan $7mn/bp; UK $1.8mn/bp. The Week Ahead: Net issuance (gross issuance less coupons less redemptions) June 6, 2025 05:38 PM GMT Global Rates Strategy | Global In the euro area, we estimate about €2 ...

Core Insights - Ascend Wellness Holdings, Inc. reported Q1 2025 net revenue of $128.0 million, a decrease of 5.9% quarter-over-quarter, with retail revenue down 6.6% and wholesale revenue down 4.4% [1][7][8] - The company generated positive cash from operations of $5.9 million, marking the ninth consecutive quarter of positive operating cash flow [1][11] - The company ended Q1 2025 with $100.0 million in cash and cash equivalents, reflecting a sequential increase of $11.7 million [1][11] Business Highlights - The company is focused on executing a densification strategy aimed at increasing store count by approximately 50% in the medium term, targeting ten new stores in 2025 [6][7] - New product launches and store openings are anticipated in the coming months to enhance consumer experience and expand access [6][7] Financial Highlights - Adjusted EBITDA for Q1 2025 was $27.0 million, representing a margin of 21.1%, a decrease of 10.7% from the previous quarter [7][11] - The net loss for Q1 2025 was $19.3 million, compared to a net loss of $16.8 million in Q4 2024 [7][10] - Total general and administrative expenses decreased to $37.1 million, or 29.0% of revenue, down from $40.8 million, or 30.0% of revenue, in Q4 2024 [10][11] Revenue Breakdown - Total net revenue of $128.0 million included retail revenue of $84.4 million and wholesale revenue of $43.6 million, both showing declines due to competitive pressures and pricing [7][8] - Gross profit for Q1 2025 was $39.6 million, or 30.9% of revenue, down from $46.9 million, or 34.5% of revenue, in Q4 2024 [9][11] Cash Flow and Balance Sheet - Free Cash Flow for Q1 2025 was $1.2 million, calculated as cash from operations minus capital expenditures [5][11] - Net Debt as of March 31, 2025, was $233.0 million, reflecting total debt less cash and cash equivalents [4][11] - The company launched a share buyback program in January 2025, repurchasing 1,571,500 shares by April 30, 2025 [7]

Core Points - Ascend Wellness Holdings, Inc. will hold a conference call on May 12, 2025, at 5:00 PM ET to discuss its first quarter 2025 financial results [1] - The conference call can be accessed via a dial-in number or a live webcast on the company's Investor Relations website [2][3] - Ascend Wellness Holdings operates in multiple states including Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania, and is involved in the cultivation and distribution of cannabis products [3]

Group 1: Economic Context - Current odds of a U.S. recession are estimated between 45% to 60%, influenced by trade policy uncertainty and potential global growth slowdown due to U.S. tariffs [1] - The auto industry is highlighted as having recession-resilient stocks [1] Group 2: Ferrari - Ferrari is recognized for its racing heritage and ultra-luxury vehicles, with stock gains that outperform industry peers and the S&P 500 [2][4] - The consumer base for Ferrari consists of high earners who can afford to purchase vehicles even during economic downturns, leading to long waiting lists and strict resale policies [5] - Ferrari maintains limited sales volume to ensure demand exceeds supply, which supports pricing power and provides flexibility during economic downturns [6] - The company has high profit margins akin to ultra-luxury brands, with new models like the F80 generating significant interest and sales [7][8] Group 3: AutoZone - AutoZone operates in a countercyclical industry, where demand for auto parts increases as consumers opt to repair rather than replace vehicles during economic downturns [9] - The company has a robust distribution model with over 7,000 stores across the U.S., Mexico, and Brazil, carrying a wide range of SKUs [11] - AutoZone has significantly reduced its shares outstanding through buybacks over the past decade, enhancing shareholder value [12] - The company is expected to remain resilient amid tariff issues, as consumers prioritize vehicle maintenance [12] Group 4: Investment Implications - Owning stocks like AutoZone and Ferrari, which have durable business models and competitive advantages, could provide resilience during economic downturns [14] - Investors are encouraged to keep AutoZone and Ferrari on their watch list regardless of economic conditions or tariff developments [14]